MSc Student
Frank completed his BSc with Honours in Biochemistry at the University of British Columbia (UBC), where he conducted undergraduate research focused on enzyme engineering. His work involved the use of error-prone PCR to engineer DNPH1, an enzyme that plays a role in the hydrolysis of the N-glycosidic bond between deoxyribose and purine or pyrimidine bases in DNA. This research laid the foundation for his deep interest in enzyme engineering and molecular design.
Building on this foundation, Frank’s MSc studies are now directed toward applying modern computational techniques for de novo design of an antibody fragment (either Fab or Fv) that targets the SARS-CoV-2 spike protein. His research aims to leverage computational biology to create novel antibody structures with potential therapeutic applications against COVID-19.